Humana Inc. lost its second lawsuit against the Centers of Medicare & Medicaid and the Department of Health & Human Services, challenging its lowered Medicare Advantage star ratings. Humana disputed ...

Humana Inc. (NYSE:HUM) lost a legal battle challenging cuts to its Medicare Advantage bonus payments, raising concerns over billions in potential revenue. Per a media report on Tuesday, a Texas judge ...

The fate of three disconnected phone calls from the Centers for Medicare & Medicaid Services could cost Humana billions of dollars. The phone calls are part of a CMS “star ratings” system that awards ...

Humana is accused of halting contractual payments per its medicare agreement with International Motors to provide plans for International Motors' retirees who are eligible for Medicare. Humana ...

Thinking about what to do with Humana stock right now? You are not alone. Healthcare stocks have been on a bit of a rollercoaster, and Humana has been no exception. Over the past month, the stock has ...

Humana must face a class action lawsuit alleging that its use of artificial intelligence to deny post-acute care to Medicaid Advantage beneficiaries became fraud when those automated decisions ...

Humana says medical costs in line with expectations Says reduced benefits in plans more significantly than others Shares rise 6% July 30 (Reuters) - Humana (HUM.N), opens new tab raised its annual ...

LOUISVILLE, Ky. (WDRB) -- Humana is now offering early retirement packages to eligible employees, raising some question marks. Humana is Louisville's 7th largest employer with 10,000 employees; some ...

Most people know the frustration of needing prior authorization from a health plan, often before they're even eligible for Medicare. Now, Humana, the second largest provider of Medicare Advantage ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc., a leading health and well-being company, today announced accelerated efforts to approve care requests as quickly as possible and reduce the ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition, making a quick turnaround unlikely. The stock isn’t a screaming value; peers like Cigna and ...